Results 81 to 90 of about 36,054 (205)
An in depth study of human papillomavirus diversity in South African women infected with HIV
, 2009 Includes abstract. Includes bibliographical references (leaves 109-129).Cervical cancer is the second most common cancer affecting women and in most developing countries it remains the leading cause of cancer deaths.
Salimo, Anna T
core
International Journal of Cancer, Volume 159, Issue 2, Page 389-400, 15 July 2026.What's new? Effective cervical cancer prevention centers around screening and testing for human papillomavirus (HPV) infection. With birth cohorts of HPV‐vaccinated women now reaching screening‐eligible ages, however, the best means to maintaining cost‐effective cervical cancer screening is unclear.
Tiago M. de Carvalho +2 more
wiley +1 more source
Investigation on Spontaneous Abortion and Human Papillomavirus Infection
, 2020 Viral infections are considered to be risk factors for spontaneous abortion (SA). Conflicting results have been reported on the association between Human Papillomavirus (HPV) and SA.
Federica Magagnoli +9 more
core +1 more source
The Patient Perspective of Living With Recurrent Respiratory Papillomatosis
The Laryngoscope, Volume 136, Issue 7, Page 3067-3078, July 2026.This study was conducted to better understand the perspectives and real‐world impact of the disease burden on patients diagnosed with recurrent respiratory papillomatosis (RRP) and caregivers who experience the disease daily. RRP results in clinical, financial, and psychosocial burdens. Increased public awareness of human papillomavirus (HPV) infection
Sara I. Pai +7 more
wiley +1 more source
Kikuchi-Fujimoto Disease: a rare type of lymphadenopathy and its plausible relationship with human papillomavirus vaccines. [PDF]
Rev Esp Quimioter, 2023 Rodríguez-Ferreras A +6 more
europepmc +1 more source
Reviews in Medical Virology, Volume 36, Issue 4, July 2026.ABSTRACT Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and is responsible for anogenital warts and several cancers. Although the effectiveness of female HPV vaccination has been well established since its introduction in 2006, no systematic review has specifically evaluated the impact of male vaccination ...
Anna Beltrame +5 more
wiley +1 more source
The objective of this study was to conduct preclinical immunogenicity and efficacy studies with several therapeutic vaccines for human papillomavirus (HPV)-16-associated cancers expressing the early antigens E5, E6, and E7 with or without E2.
Mohadeseh Hasanpourghadi +6 more
core +1 more source
International Journal of Cancer, Volume 158, Issue 12, Page 3141-3151, 15 June 2026.What's new? Persistent infection with high‐risk human papillomavirus (HPV) causes most invasive cervical cancer cases, leading many countries to transition from cytology to primary HPV‐based screening. Despite the benefits, HPV‐based screening may also lead to unnecessary procedures, psychological burden, and strain on healthcare systems.
Kelsi R. Kroon +2 more
wiley +1 more source
Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma
Molecular Oncology, Volume 20, Issue 6, Page 1643-1660, June 2026.Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra +6 more
wiley +1 more source
Human papillomavirus vaccines: A great leap forward. [PDF]
Case Rep Womens Health, 2022 Frevert ML, Taran FA.
europepmc +1 more source